223 related articles for article (PubMed ID: 22763379)
21. Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancers.
Joo JE; Mahmood K; Walker R; Georgeson P; Candiloro I; Clendenning M; Como J; Joseland S; Preston S; Graversen L; Wilding M; Field M; Lemon M; Wakeling J; Marfan H; Susman R; Isbister J; Edwards E; Bowman M; Kirk J; Ip E; McKay L; Antill Y; Hopper JL; Boussioutas A; Macrae FA; Dobrovic A; Jenkins MA; Rosty C; Winship IM; Buchanan DD
Clin Epigenetics; 2023 Jun; 15(1):95. PubMed ID: 37270516
[TBL] [Abstract][Full Text] [Related]
22. Primary constitutional MLH1 epimutations: a focal epigenetic event.
Dámaso E; Castillejo A; Arias MDM; Canet-Hermida J; Navarro M; Del Valle J; Campos O; Fernández A; Marín F; Turchetti D; García-Díaz JD; Lázaro C; Genuardi M; Rueda D; Alonso Á; Soto JL; Hitchins M; Pineda M; Capellá G
Br J Cancer; 2018 Oct; 119(8):978-987. PubMed ID: 30283143
[TBL] [Abstract][Full Text] [Related]
23. MLH1-methylated endometrial cancer under 60 years of age as the "sentinel" cancer in female carriers of high-risk constitutional MLH1 epimutation.
Hitchins MP; Alvarez R; Zhou L; Aguirre F; Dámaso E; Pineda M; Capella G; Wong JJ; Yuan X; Ryan SR; Sathe DS; Baxter MD; Cannon T; Biswas R; DeMarco T; Grzelak D; Hampel H; Pearlman R
Gynecol Oncol; 2023 Apr; 171():129-140. PubMed ID: 36893489
[TBL] [Abstract][Full Text] [Related]
24. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC.
Morak M; Schackert HK; Rahner N; Betz B; Ebert M; Walldorf C; Royer-Pokora B; Schulmann K; von Knebel-Doeberitz M; Dietmaier W; Keller G; Kerker B; Leitner G; Holinski-Feder E
Eur J Hum Genet; 2008 Jul; 16(7):804-11. PubMed ID: 18301449
[TBL] [Abstract][Full Text] [Related]
25. Constitutional MLH1 methylation presenting with colonic polyposis syndrome and not Lynch syndrome.
Kidambi TD; Blanco A; Van Ziffle J; Terdiman JP
Fam Cancer; 2016 Apr; 15(2):275-80. PubMed ID: 26781822
[TBL] [Abstract][Full Text] [Related]
26. Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility.
Hitchins MP
Adv Genet; 2010; 70():201-43. PubMed ID: 20920750
[TBL] [Abstract][Full Text] [Related]
27. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients.
Alemayehu A; Sebova K; Fridrichova I
Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713
[TBL] [Abstract][Full Text] [Related]
28. Constitutional MLH1 Methylation Is a Major Contributor to Mismatch Repair-Deficient, MLH1-Methylated Colorectal Cancer in Patients Aged 55 Years and Younger.
Hitchins MP; Dámaso E; Alvarez R; Zhou L; Hu Y; Diniz MA; Pineda M; Capella G; Pearlman R; Hampel H
J Natl Compr Canc Netw; 2023 Jul; 21(7):743-752.e11. PubMed ID: 37433431
[TBL] [Abstract][Full Text] [Related]
29. Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome.
Morak M; Koehler U; Schackert HK; Steinke V; Royer-Pokora B; Schulmann K; Kloor M; Höchter W; Weingart J; Keiling C; Massdorf T; Holinski-Feder E;
J Med Genet; 2011 Aug; 48(8):513-9. PubMed ID: 21712435
[TBL] [Abstract][Full Text] [Related]
30. Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome.
Rahner N; Friedrichs N; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
J Pathol; 2008 Jan; 214(1):10-6. PubMed ID: 17973250
[TBL] [Abstract][Full Text] [Related]
31. Inheritance of a cancer-associated MLH1 germ-line epimutation.
Hitchins MP; Wong JJ; Suthers G; Suter CM; Martin DI; Hawkins NJ; Ward RL
N Engl J Med; 2007 Feb; 356(7):697-705. PubMed ID: 17301300
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of the
Morak M; Ibisler A; Keller G; Jessen E; Laner A; Gonzales-Fassrainer D; Locher M; Massdorf T; Nissen AM; Benet-Pagès A; Holinski-Feder E
J Med Genet; 2018 Apr; 55(4):240-248. PubMed ID: 29472279
[TBL] [Abstract][Full Text] [Related]
33. Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair.
Case AS; Zighelboim I; Mutch DG; Babb SA; Schmidt AP; Whelan AJ; Thibodeau SN; Goodfellow PJ
Gynecol Oncol; 2008 Feb; 108(2):438-44. PubMed ID: 18022218
[TBL] [Abstract][Full Text] [Related]
34. Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome.
Pérez-Carbonell L; Alenda C; Payá A; Castillejo A; Barberá VM; Guillén C; Rojas E; Acame N; Gutiérrez-Aviñó FJ; Castells A; Llor X; Andreu M; Soto JL; Jover R
J Mol Diagn; 2010 Jul; 12(4):498-504. PubMed ID: 20489114
[TBL] [Abstract][Full Text] [Related]
35. MLH1 epimutation is a rare mechanism for Lynch syndrome: A case report and review of the literature.
Zyla R; Graham T; Aronson M; Velsher L; Mrkonjic M; Turashvili G
Genes Chromosomes Cancer; 2021 Sep; 60(9):635-639. PubMed ID: 33934415
[TBL] [Abstract][Full Text] [Related]
36. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
37. Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5'UTR.
Hitchins MP; Rapkins RW; Kwok CT; Srivastava S; Wong JJ; Khachigian LM; Polly P; Goldblatt J; Ward RL
Cancer Cell; 2011 Aug; 20(2):200-13. PubMed ID: 21840485
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination.
Aissi-Ben Moussa S; Moussa A; Lovecchio T; Kourda N; Najjar T; Ben Jilani S; El Gaaied A; Porchet N; Manai M; Buisine MP
Fam Cancer; 2009; 8(2):119-26. PubMed ID: 18792805
[TBL] [Abstract][Full Text] [Related]
39. Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability.
Nakagawa H; Nagasaka T; Cullings HM; Notohara K; Hoshijima N; Young J; Lynch HT; Tanaka N; Matsubara N
Oncol Rep; 2009 Jun; 21(6):1577-83. PubMed ID: 19424639
[TBL] [Abstract][Full Text] [Related]
40. MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families.
Zhou HH; Yan SY; Zhou XY; Du X; Zhang TM; Cai X; Lu YM; Cai SJ; Shi DR
World J Gastroenterol; 2008 Dec; 14(48):7329-34. PubMed ID: 19109866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]